HIMS Commentator
TSLL Gain Hunter(Video) Hims Major Shareholder In-Depth Interview: Dual Opportunities in Peptides and AI
On April 18th Eastern Time, the Hims House channel conducted an interview with hedge fund manager Jonah Lupton. Lupton shared his investment rationale as a major shareholder of Hims & Hers (HIMS), focusing on how peptides and AI are set to become the company's core growth engines in the future.$Defiance Daily Target 2X Long HIMS ETF(HIMZ.US) $Hims & Hers Health(HIMS.US)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
